NCT01438086View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

December 31, 2016

Conditions
Heart FailureMyocardial Infarction
Interventions
DRUG

mecasermin

Intracoronary bolus

DRUG

mecasermin

Intracoronary bolus

DRUG

0.9% sodium chloride injection

Intracoronary bolus

Trial Locations (2)

Unknown

Cork University Hospital, Cork

Leiden University Medical Center, Leiden

All Listed Sponsors
lead

University College Cork

OTHER

NCT01438086 - Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack | Biotech Hunter | Biotech Hunter